Related Experiment Video
Updated: Jun 16, 2026
07:22
A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
Andrea L Ferris1, Xiaolin Wu, Christina M Hughes
1HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702, USA.
Summary
Researchers modified Lens epithelium-derived growth factor (LEDGF) fusion proteins to alter HIV-1 DNA integration sites. Replacing LEDGF’s N terminus with different chromatin binding domains redirected integration, offering potential gene therapy solutions.
Area of Science:
- Molecular Biology
- Virology
- Epigenetics
Background:
- Lens epithelium-derived growth factor (LEDGF) is crucial for HIV-1 DNA integration.
- LEDGF normally targets integration to actively transcribed genes via its N-terminal chromatin binding.
- Alterations in LEDGF can change integration specificity, impacting retroviral vector safety.
Purpose of the Study:
- To investigate if replacing LEDGF's N terminus with alternative chromatin binding domains (CBDs) can redirect HIV-1 DNA integration.
- To assess the impact of specific CBDs, ING2 PHD finger and HP1alpha chromodomain, on integration site selection.
Main Methods:
- Construction of fusion proteins linking LEDGF's integrase binding domain (IBD) to different CBDs (ING2 PHD, HP1alpha chromodomain).
- Analysis of HIV-1 DNA integration site distribution mediated by these engineered fusion proteins.
- Characterization of histone mark binding specificities for the chosen CBDs (H3K4me3 for ING2 PHD, H3K9me2,3 for HP1alpha).
Main Results:
- Fusion protein with ING2 PHD finger directed integration near transcriptional start sites, similar to native LEDGF.
- Fusion protein with HP1alpha chromodomain directed integration to novel sites, distinct from both native LEDGF and ING2 PHD fusions.
- Specific CBDs confer unique integration preferences, demonstrating the plasticity of LEDGF-mediated targeting.
Conclusions:
- Modifying LEDGF with specific CBDs allows for redirection of HIV-1 integration.
- This approach offers a potential strategy to mitigate risks of oncogene activation in gene therapy vectors.
- Understanding LEDGF-chromatin interactions is key to engineering safer retroviral integration.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...